{
    "organizations": [],
    "uuid": "936181f5b1975c8be850f67fc2f5056d0fbb93e6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zynerba-pharma-plans-to-conduct-si/brief-zynerba-pharma-plans-to-conduct-single-pivotal-study-of-zyn002-in-fragile-x-syndrome-to-support-nda-filing-idUSFWN1QN0EG",
    "ord_in_thread": 0,
    "title": "BRIEF-Zynerba Pharma Plans To Conduct Single Pivotal Study Of ZYN002 In Fragile X Syndrome To Support NDA Filing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Zynerba Pharmaceuticals Inc:\n* ZYNERBA PHARMACEUTICALS ANNOUNCES POSITIVE MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION AND PLANS TO CONDUCT A SINGLE PIVOTAL STUDY OF ZYN002 IN FRAGILE X SYNDROME TO SUPPORT AN NDA FILING\n* ZYNERBA - EXPECTS TO INITIATE SINGLE PIVOTAL STUDY MID-YEAR 2018 TO SUPPORT NDA FOR ZYN002 IN FXS\n* ZYNERBA PHARMACEUTICALS SAYS FDA & CO ARE IN AGREEMENT OVER PRIMARY & KEY SECONDARY ENDPOINTS FOR ZYN002 IN FRAGILE X SYNDROME Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-05T20:31:00.000+02:00",
    "crawled": "2018-03-06T22:38:22.034+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "zynerba",
        "pharmaceutical",
        "inc",
        "zynerba",
        "pharmaceutical",
        "announces",
        "positive",
        "meeting",
        "food",
        "drug",
        "administration",
        "plan",
        "conduct",
        "single",
        "pivotal",
        "study",
        "zyn002",
        "fragile",
        "x",
        "syndrome",
        "support",
        "nda",
        "filing",
        "zynerba",
        "expects",
        "initiate",
        "single",
        "pivotal",
        "study",
        "support",
        "nda",
        "zyn002",
        "fxs",
        "zynerba",
        "pharmaceutical",
        "say",
        "fda",
        "co",
        "agreement",
        "primary",
        "key",
        "secondary",
        "endpoint",
        "zyn002",
        "fragile",
        "x",
        "syndrome",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}